Veterinary Compounding in Small Animals: A Clinical Pharmacologist's Perspective

Veterinary Clinics of North America - Small Animal Practice

Volumn 36, Issue 5, 2006, Pages 1129-1173

  Boothe, Dawn Merton ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMITRIPTYLINE; BENZOIC ACID DERIVATIVE; BETA LACTAM ANTIBIOTIC; BOLDENONE; BOLDENONE UNDECENOATE; CHLORAMPHENICOL; CISAPRIDE; CYCLOSPORIN; DIAZEPAM; DIETHYLSTILBESTROL; DRUG PRESERVATIVE; ENROFLOXACIN; FLUOXETINE; ISOPHANE INSULIN; KETOPROFEN; METRONIDAZOLE; OMEPRAZOLE; OPIATE; PHENYLPROPANOLAMINE; PIMOBENDAN; POLOXAMER; POTASSIUM BROMIDE; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STANOZOLOL; THIAMAZOLE; UNINDEXED DRUG; VETERINARY DRUG;

ANIMAL CARE; ANIMAL DISEASE; CONSENSUS; DRUG ADMINISTRATION ROUTE; DRUG APPROVAL; DRUG CROSS REACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG LABELING; DRUG LEGISLATION; DRUG SAFETY; DRUG STORAGE; EXCIPIENT COMPATIBILITY; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL ERROR; MEDICAL PROFESSION; MEDICAL SOCIETY; NONHUMAN; OFF LABEL DRUG USE; PARTICLE SIZE; PH; PHARMACIST; PRACTICE GUIDELINE; PRESCRIPTION; PUBLIC HEALTH; REVIEW; SELF DISCLOSURE; TREATMENT FAILURE; UNITED STATES; VETERINARY MEDICINE;

ANIMALS; DRUG COMPOUNDING; GUIDELINES; GUIDELINES AS TOPIC; PHARMACOLOGY, CLINICAL; QUALITY CONTROL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VETERINARY DRUGS; VETERINARY MEDICINE;

ANIMALIA;

EID: 33748681304     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2006.07.003     Document Type: Review

References (58)

1. Available at: http://www.iacprx.org/index.html. Accessed July 15, 2004.
2. Notices. Fed Regist 71 63 (2006) 16593-16596
3. Bender GA. History of pharmacy. College of Pharmacy. Available at: www.pharmacy.wsu.edu/history. Accessed August 17, 2006.
4. Thompson J. The United States Pharmacopeia. A leader in protection and promotion of health. Journal of the Pharmacy Society of Wisconsin (2002) 34-38
5. United States Pharmacopeia. The United States pharmacopeia/national formulary (USP 27-NF 22) (2004), United States Pharmacopeia, Rockville (MD)
6. Allen L. Compounding. Presented at the USP Stakeholders Meeting. Baltimore, August 2002.
7. Bradley E.W. Improving profitability with veterinary compounding. International Journal of Pharmaceutical Compounding 3 (1999) 180-181
8. Davis J. Compounding for creatures: what works. International Journal of Pharmaceutical Compounding 3 (1999) 182-185
9. Paoletti J. Veterinary flavor suggestions. International Journal of Pharmaceutical Compounding 3 (1999) 186
10. Yoakum J. Compounded injectables for veterinary use. International Journal of Pharmaceutical Compounding 5 (2001) 107
11. Hudson S. Call of the wild: compounding for zoos and exotics. International Journal of Pharmaceutical Compounding 3 (1999) 176-179
12. Swann JP. History of the FDA. FDA history office. Available at: www.fda.gov/oc/history/historyoffda. Accessed August 17, 2006.
13. Seigner A.W. When is compounding for animals legal?. International Journal of Pharmaceutical Compounding 3 (1999) 188-192
14. Chan D.S. Regulatory issues for the use of bulk drugs in veterinary compounding. International Journal of Pharmaceutical Compounding 5 (2001) 97-100
15. US Food and Drug Administration. Animal Medicinal Drug Use Clarification Act of 1994. Available at: http://www.fda.gov/cvm/amducatoc.htm. Accessed August 29, 2006.
16. American Veterinary Medical Association. Extra label drug use algorithm. Available at: http://www.avma.org/scienact/amduca/amduca2.asp. Accessed August 17, 2006.
17. Anonymous. The top 10 veterinary compounded products. International Journal of Pharmaceutical Compounding 3 (1999) 183
18. International Academy of Compounding Pharmacists. Available at: www.iacprx.org/vetissue.htm.
19. Anonymous. DEA revokes pharmacy's registration. Available at: http://www.avma.org/onlnews/javma/jun06/060601i.asp. Accessed August 17, 2006.
20. Anonymous. When can a veterinarian import a foreign durg? Available at: http://www.avma.org/onlnews/javma/aug05/050815f.asp. Accessed August 17, 2006.
21. National Association of Board of Pharmacies. Available at: www.nabp.net. Accessed August 17, 2006.
22. American Veterinary Medical Association. Available at: http://www.avma.org/issues/drugs/compounding/default.asp. Accessed August 17, 2006.
23. Professional Compounding Accreditation Board. Available at: http://www.pcab.info. Accessed August 17, 2006.
24. Davidson G. To benzoate or not to benzoate: Cats are the question. International Journal of Pharmaceutical Compounding 5 (2001) 89-90
25. Connors K.A., Amidon G.L., and Stella V.J. Chemical stability of pharmaceuticals (1986), John Wiley, New York
26. Allen L. Secondum artem. Current and practical compounding information for the pharmacist (2004), Paddock Laboratories, Minneapolis (MN) p. 1-3
27. Nieto J.E., Spier S., Pipers F.S., et al. Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training. J Am Vet Med Assoc 221 8 (2002) 1139-1143
28. Kukamich B, Papich M. Fluorinated quinolone stability in vehicles for oral administration [abstract]. In: Proceedings of the American College of Veterinary Internal Medicine. Charlotte (NC), 2003. p. 285.
29. Mistry B., Samuel L., Bowden S., et al. Simplifying oral drug therapy for patients with swallowing difficulties. Pharm J 254 (1995) 808-809
30. Canadian Society of Hospital Pharmacists. Extemporaneous oral liquid dosage preparations (1988), Canadian Society of Hospital Pharmacists, Toronto
31. USP pharmacist's pharmacopeia (2005), US Pharmacopeia, Rockville (MD)
32. Bedford P.G.C., and Clarke M.A. Suspected benzoic acid poisoning in the cat. Vet Rec 88 (1971) 599-601
33. Flynn E.A., Pearson R.E., and Barker K.N. Observational study of accuracy in compounding i.v. admixtures at five hospitals. Am J Health Syst Pharm 54 (1997) 904-912
34. Buerger DK. Parenteral nutrition safe practices: a new roadmap for improved patient care. American Society of Consultant Pharmacists. Available at: www.ascp.com/public/pubs/tcp/1998/nov/roadmap.shtml. Accessed August 17, 2006.
35. Stanley DS, Thomasy MS, Skinner W. Comparison for pharmaceutical equivalence of FDA-approved products and compounded preparations of ketoprofen, amikacin, and boldenone In: Proceedings of the 49th Annual Convention of the American Association of Equine Practitioners. New Orleans (LA); 2003.
36. In: Gennaro A.R. (Ed). Remington: the science and practice of pharmacy. 20th edition (2000), Mack Publishing Company, Easton (PA)
37. Trissel L.A. Stability of compounded formulations (1996), American Pharmaceutical Association, Washington (DC)
38. Trissel L.A. Handbook on injectable drugs. 8th edition (2000), American Society of Hospital Pharmacists, Bethesda (MD)
39. King's guide to parenteral admixtures. Pacemarq, Inc. St. Louis (MO).
40. Woods D.J. Formulation in pharmacy practice (1993), Healthcare Otago, Dunedin (New Zealand)
41. American Society of Hospital Pharmacists. Committee on Extemporaneous Formulations. Handbook on extemporaneous formulations (1987), American Society of Hospital Pharmacists, Bethesda (MD)
42. Nahata M.C., and Hipple T.F. Pediatric drug formulations (1990), Harvey Whitney, Cincinnati (OH)
43. Harvey A. Equipment for large-volume aseptic veterinary compounding. International Journal of Pharmaceutical Compounding 5 (2001) 106
44. Anonymous. The history of Marty Jones. Intern J Pharmaceut Compound 7 (2003) 180-183
45. Willimann H., Walde P., Luisi P.L., et al. Lecithin organogel as matrix for transdermal transport of drugs. J Pharm Sci 81 (1992) 871-874
46. Lavaud F., Perdu D., Prvost A., et al. Baker's asthma related to soybean lecithin exposure. Allergy 49 (1994) 159-162
47. Palm M., Moneret-Vautrin D.A., Kanny G., et al. Food allergy to egg and soy lecithins. Allergy 54 (1999) 1116-1117
48. Hoffman S.B., Yoder A.R., and Trepanier L.A. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. J Vet Pharmacol Ther 25 3 (2002) 189-193
49. Hoffmann G., Marks S.L., Taboada J., et al. Transdermal methimazole treatment in cats with hyperthyroidism. J Feline Med Surg 5 2 (2003) 77-82
50. Sartor LL, Trepanier LA, Kroll M, et al. Clinical efficacy of transdermal methimazole in cats with hyperthyroidism [abstract]. In: Proceedings of the American College of Veterinary Internal Medicine. 2003. p. 21.
51. Krotscheck U, Boothe DM, Boothe HW. Evaluation of a pluronic lecithin organogel for transdermal delivery of fentanyl and morphine in dogs [abstract]. In: Proceedings of the American College of Veterinary Internal Medicine Annual Forum, Charlotte (NC); 2003. p. 21.
52. DeFrancesco TC. Transdermal cardiac therapy in cats: the NCSU experience. In: Proceedings of the American College of Veterinary Internal Medicine Annual Forum, Denver (CO); 2004. p. 22.
53. Ciribassi J., Luescher A., and Pasloske K.S. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats. Am J Vet Res 64 8 (2003) 994-998
54. Mealey K.M., Peck K.E., Bennett B.S., et al. Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats. J Vet Intern Med 18 1 (2004) 43-46
55. Bennett N., Papich M.G., Hoenig M., et al. Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats. Am J Vet Res 66 4 (2005) 581-588
56. Willis-Goulet H.S., Schmidt B.A., Nicklin C.F., et al. Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): pilot study. Veterinary Dermatology 14 (2003) 83-89
57. Davidson G. Veterinary transdermal medications: A to Z. International Journal of Pharmaceutical Compounding 7 (2003) 206-209
58. Riviere J.E., and Papich M.G. Potential problems of developing transdermal patches for veterinary applications. Adv Drug Deliv Rev 50 (2001) 175-203